Article abstract-Objective: To determine whether MRI volumetric measurement of the entorhinal cortex could detect structural damage and lateralize the seizure focus in patients with temporal lobe epilepsy in whom no measurable hippocampal abnormalities were found. Background: A reduction in the volume of the entorhinal cortex ipsilateral to the seizure focus in patients with intractable temporal lobe epilepsy and hippocampal atrophy was recently shown. Methods: MRI volumetric analysis of the entorhinal cortex was performed using a T1-weighted three-dimensional gradient echo sequence in 24 control subjects and 22 patients with temporal lobe epilepsy and normal hippocampal volumes. Thirteen patients underwent surgery, with a mean postoperative follow-up of 36 months. Results: Group analysis (multivariate analysis of variance) showed a reduction in the volume of the entorhinal cortex ipsilateral to the seizure focus in patients with left (p Ͻ 0.0001) and right temporal lobe epilepsy (p Ͻ 0.0001). Lateralization of the seizure focus could be done in 14 of 22 patients (64%) based on entorhinal cortex volumetry. Conclusion: Entorhinal cortex atrophy ipsilateral to the seizure focus supports the presence of structural damage in the mesial temporal lobe in patients with temporal lobe epilepsy and normal hippocampal volumes and emphasizes the participation of the entorhinal cortex in the pathogenesis of this disorder. NEUROLOGY 2001;56:1335-1339 Hippocampal sclerosis is the most common pathology underlying pharmacologically intractable temporal lobe epilepsy (TLE)
Hippocampal sclerosis is the most common pathology underlying pharmacologically intractable temporal lobe epilepsy (TLE) 1 . For the past 10 years, advances in neuroimaging have had a major impact on in vivo detection of hippocampal sclerosis. A common MRI finding in patients with TLE is hippocampal atrophy on T1-weighted images. 2 The sensitivity of MRI visual analysis can be increased by the use of quantitative MRI techniques. Because it is relatively easy to diagnose hippocampal sclerosis and quantitate hippocampal atrophy preoperatively, MRI studies in TLE have put the emphasis on the hippocampus, and little attention has been paid to changes in the remaining components of medial temporal lobe, such as the entorhinal cortex (EC).
Hippocampal atrophy is found in 85% of patients with TLE, and the epileptic focus is lateralized in about 80% of patients. 3 Hippocampal volumes are normal in about 15% of patients with intractable TLE, 4 even though postoperative specimens from the majority of these individuals demonstrate histopathologic evidence of hippocampal sclerosis. [4] [5] [6] [7] [8] We recently showed a reduction in the volume of the EC ipsilateral to the seizure focus in patients with intractable TLE and hippocampal atrophy. 9 We hypothesized that MRI volumetric measurement of the EC could detect structural damage in patients with TLE in whom no measurable hippocampal abnormalities are found. Furthermore, we were interested in determining the usefulness of measuring EC volume in the lateralization of the epileptic focus in this group of patients.
Methods. Subjects. We selected 22 patients with medically intractable TLE (mean age, 34 years; range, 21 to 50) and normal hippocampal and amygdalar volumes on volumetric MRI. These 22 patients were compared with 24 subjects without neurologic symptoms recruited among the employees of our Brain Imaging Center (mean age, 30 years; range, 20 to 51).
Lateralization of seizure focus. Seizure type and site of seizure onset were determined by a comprehensive evaluation that included detailed history taking, neurologic examination, review of medical and EEG records, and neuropsychological evaluation. The seizure focus was determined by predominantly ipsilateral interictal epileptic abnormalities (70% cutoff) by unequivocal unilateral seizure onset recorded during prolonged video EEG monitoring using sphenoidal electrodes. Four patients had depth electrode studies. Based on these criteria, patients with TLE were divided into those with a left-sided (n ϭ 12) or a right-sided (n ϭ 10) seizure focus. Thirteen patients had surgery: five underwent a selective amygdalohippocampec-tomy and eight underwent temporal cortical resection with amygdalohippocampectomy. As tissue was removed by subpial aspiration, histopathologic information from the EC was not available. Qualitative histopathologic examination 10 revealed hippocampal sclerosis in nine patients. Specimens for histopathologic assessment of the hippocampus were unsuitable in five patients. Figure 1 illustrates the histopathology of the hippocampus in a patient with normal hippocampal volumes and in a patient with hippocampal atrophy on MRI. Ten patients have been seizure free (Engel class I) since surgery, and three had rare disabling seizures (Engel class II). The mean postoperative follow-up was 36 months (range, 14 months to 6 years).
MRI scanning. Images were acquired on a 1.5-T Gyroscan device (Philips Medical System, Eindhoven, the Netherlands), using a T1-weighted, three-dimensional gradient echo sequence (repetition time, 18 ms; echo time, 10 ms; 1 signal average; flip angle 30°; matrix 256 ϫ 256; field of view, 250 mm; slice thickness, 1 mm). Approximately 170 slices with an isotropic voxel size of 1 mm 3 were acquired. Images were automatically registered into stereotaxic space 11 to adjust for differences in total brain volume and brain orientation, and to facilitate the identification of boundaries by minimizing variability in slice orientation. 12 This transformation maximized the crosscorrelation between each individual's MR image and a target image consisting of the average of over 300 normal MR images already registered into stereotaxic coordinates.
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Each image underwent automated correction for intensity nonuniformity (due to radiofrequency inhomogeneity of the MR scanner) and intensity standardization. 13 This correction produces consistent relative gray matter, white matter, and CSF intensities. Volumetric analysis was performed on a Silicon Graphics (Mountain View, CA) workstation. The EC, hippocampus, and amygdala were segmented manually. The EC boundaries were as defined by Bernasconi et al. 9 (figure 2). The hippocampal and the amygdalar boundaries were defined according to Watson et al. 14 The segmentation was done using the mouse-driven software package DISPLAY, developed at the Brain Imaging Center of the Montreal Neurologic Institute. This software allows simultaneous viewing of volumes in coronal, sagittal, and horizontal orientations.
Statistical analysis. The statistical significance of differences in mean volumes between right and left sides was assessed using the paired Student's t-test. Group differences for volumes was examined using a multivariate analysis of variance (MANOVA) with one between-subject grouping factor (groups: control subjects, patients with left TLE, patients with right TLE) and two within-subject factors: factor 1, hemisphere (left or right); factor 2, structure (EC, hippocampus, or amygdala). MANOVA was followed by Tukey Honest Significant Difference post hoc comparisons. For each individual, left-right asymmetries in entorhinal, hippocampal, and amygdalar volumes were calculated as follows: (L Ϫ R)/(L ϩ R)/2, where L and R refer to the mean left and right volume of each structure. Group differences in left-right asymmetries were examined using MANOVA with one between-subject grouping factor (group: control subjects, patients with left TLE, patients with right TLE) and one within-subject grouping factor (structure: EC, hippocampus, or amygdala). MANOVA was followed by Bonferroni-corrected planned comparisons. For analysis of individual patients, we considered as abnormal values that were 2 SD below the mean of normal subjects.
Results. The mean volumes of the EC, hippocampus, and amygdala in control subjects and patients with TLE ; p Ͻ 0.05). The mean left-right asymmetry scores were Ϫ0.04 (SD, 0.01) for the EC, Ϫ0.07 (SD, 0.07) for the hippocampus, and Ϫ0.04 (SD, 0.09) for the amygdala.
Group analysis. Neither the mean hippocampal or amygdalar volumes nor their mean left-right volume asymmetry scores were different in patients with TLE compared with control subjects (p Ͼ 1.00). Results of group analysis for MRI volumetry of the EC are shown in figure  3 . In patients with left TLE, both the left EC (p Ͻ 0.0001) and right EC (p ϭ 0.002) were smaller than in normal subjects, and there was a significant asymmetry (left EC smaller than right EC) (p ϭ 0.04). In patients with right TLE, the right EC was smaller than in control subjects (p Ͻ 0.0001) and there was also a significant asymmetry.
Individual analysis. Based on a 2-SD cutoff from the mean of control subjects, neither hippocampal nor amygdalar volumes could lateralize the seizure focus. In 14/22 patients (64%) there was a significant atrophy of the EC ipsilateral to the seizure focus. In 3/22 (14%) there was bilateral atrophy of the EC, which was not significantly asymmetric. The volume of the EC was normal in 5/22 patients (23%). Figure 4 illustrates an MR image from a patient with right TLE and normal hippocampal volumes, in whom there is an obvious atrophy of the right EC.
Discussion. Our data revealed a 20% reduction in the volume of the EC ipsilateral to the seizure focus in patients with TLE and normal hippocampal volumes. We were able to correctly lateralize the seizure focus in 64% of these patients. Volumetric measurement of the EC is therefore important in the MRI evaluation of patients with TLE, because it allows detection of structural abnormalities in the mesial temporal lobe that would have been missed by measuring the volumes of the amygdala or the hippocampus alone.
The presence of EC atrophy on MRI in almost all patients with TLE with hippocampal atrophy, 9 as well as in the majority of patients in whom no measurable hippocampal abnormalities were found, suggests a greater susceptibility of EC to injury in TLE. The nature of this injury is not entirely clear.
An increasing number of studies have shown evidence for the participation of the EC in the genesis of TLE. In vitro the EC is able to generate spontaneous epileptiform activity independent of input from the hippocampus 15 and may have a lower threshold for seizure elicitation than the hippocampus. 16 Injection of kainic acid directly in the rat EC consistently induces cell damage in the hippocampus, particularly in the CA1 subfield, 17 comparable to the neuropathologic damage observed in human TLE. In patients with intractable TLE, investigations with stereotactically implanted depth electrodes have shown that seizures may originate in the EC. 18 Neuropathologic examination of surgically resected specimens has revealed cell loss in layer III of the EC. 19 Furthermore, removal of the EC seems to be an important factor in determining seizure freedom after temporal lobe surgery, 20, 21 suggesting that the EC plays a pivotal role in the neuronal circuitry necessary for seizure activity.
It remains unclear whether patients with TLE [22] [23] [24] It may be that the hippocampus is particularly sensitive to febrile convulsions. Consequently, the development of hippocampal sclerosis, and its in vivo correlate hippocampal atrophy, may be more severe in patients who had febrile convulsions as opposed to patients with TLE who did not have prolonged febrile convulsions.
The absence of hippocampal atrophy in our patients does not exclude the possibility that the hippocampus was structurally abnormal. In fact, nine of the 12 patients who underwent surgery had evidence of hippocampal sclerosis based on a qualitative histopathologic analysis. Using quantitative techniques, King at al. 7 showed that patients with normal hippocampal volume have less CA1 cell loss and fewer glial cells in CA1 as compared with patients with hippocampal atrophy. Moreover, we previously demonstrated that T2 relaxometry could detect hippocampal abnormalities in patients with TLE and normal hippocampal volumes. 25 It may be that in our patients, an undetermined initial injury to the EC contributed to long-lasting changes in excitability and cell loss, which then led to secondary damage to the hippocampus in some patients. 
